The reasons for choosing these cells were (a) reports of frequent radioresistance in glioblastoma and lung cancer patients, and (b) PRMT5-mediated promotion of DNA damage repair in both A549 and U87MG cells (13, 32, 33). The gene discussed is PRMT5; the disease is lung carcinoma.